Ginkgo Bioworks: Scaling Science, Not Revenue [Seeking Alpha]
Ginkgo Bioworks Holdings, Inc. (DNA)
Company Research
Source: Seeking Alpha
Newer products and services have done little to change this situation, and it's unclear if or when a return to growth will occur. DNA's cost-cutting efforts have significantly reduced cash burn, but without meaningful growth, the company is unlikely to reach breakeven. The combination of weak growth, elevated cash burn, and dilution from SBC is likely to further pressure Ginkgo's stock. bymuratdeniz/iStock via Getty Images Ginkgo Bioworks Holdings, Inc.'s ( DNA ) business remained steady in the third quarter, and guidance suggests this situation will persist until at least the end of the year. While cost-cutting efforts are helping to reduce Ginkgo's cash burn, the company needs to return This article was written by Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not rec
Show less
Read more
Impact Snapshot
Event Time:
DNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DNA alerts
High impacting Ginkgo Bioworks Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
DNA
News
- STRM.BIO Awarded ARPA-H Contract to Advance Megakaryocyte-Derived Vesicle Platform for In Vivo Cell Engineering and Gene TherapyPR Newswire
- Will Ginkgo Bioworks (DNA) Leverage ARPA-H Partnership to Advance Its Oral Therapeutics Ambitions? [Yahoo! Finance]Yahoo! Finance
- Ginkgo Bioworks (DNA): Rethinking Valuation After New University Collaboration in ARPA-H MIGHTY Oral Health Initiative [Yahoo! Finance]Yahoo! Finance
- Ginkgo Bioworks Partners on Illinois-Led Team to Develop Innovative New Treatments for Oral Health [Yahoo! Finance]Yahoo! Finance
- Ginkgo Bioworks Partners on Illinois-Led Team to Develop Innovative New Treatments for Oral HealthPR Newswire
DNA
Earnings
- 11/6/25 - Miss
DNA
Sec Filings
- 11/14/25 - Form SCHEDULE
- 11/12/25 - Form 144
- 11/6/25 - Form 10-Q
- DNA's page on the SEC website